Evidence Builds for Immunotherapy Combos in SCLC – OncLive
OncLive |
Evidence Builds for Immunotherapy Combos in SCLC
OncLive Increasing evidence suggests that immune responses against SCLC cells make immunotherapy a rational approach. Preclinical data show that certain chemotherapeutic regimens may augment the immunotherapeutic response in lung cancer. In the M109 mouse … |
